-
1
-
-
0027370108
-
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
-
The Diabetes Control and Complications Trial Research Group
-
The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977-86.
-
(1993)
N Engl J Med
, vol.329
, Issue.14
, pp. 977-986
-
-
-
2
-
-
0032511583
-
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
-
UK Prospective Diabetes Study (UKPDS) Group
-
UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352(9131):837-53.
-
(1998)
Lancet
, vol.352
, Issue.9131
, pp. 837-853
-
-
-
3
-
-
33645745733
-
Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes
-
Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, Colette C. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA. 2006;295(14):1681-7.
-
(2006)
JAMA
, vol.295
, Issue.14
, pp. 1681-1687
-
-
Monnier, L.1
Mas, E.2
Ginet, C.3
Michel, F.4
Villon, L.5
Cristol, J.P.6
Colette, C.7
-
4
-
-
33645732339
-
Glycemic variability: A hemoglobin A1c-independent risk factor for diabetic complications
-
Brownlee M, Hirsch IB. Glycemic variability: a hemoglobin A1c-independent risk factor for diabetic complications. JAMA. 2006;295(14):1707-8.
-
(2006)
JAMA
, vol.295
, Issue.14
, pp. 1707-1708
-
-
Brownlee, M.1
Hirsch, I.B.2
-
5
-
-
58849150951
-
A1C variability and the risk of microvascular complications in type 1 diabetes: Data from the Diabetes Control and Complications Trial
-
Kilpatrick ES, Rigby AS, Atkin SL. A1C variability and the risk of microvascular complications in type 1 diabetes: data from the Diabetes Control and Complications Trial. Diabetes Care. 2008;31(11):2198-202.
-
(2008)
Diabetes Care
, vol.31
, Issue.11
, pp. 2198-2202
-
-
Kilpatrick, E.S.1
Rigby, A.S.2
Atkin, S.L.3
-
6
-
-
48449098502
-
Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients
-
Ceriello A, Esposito K, Piconi L, Ihnat MA, Thorpe JE, Testa R, Boemi M, Giugliano D. Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes. 2008;57(5):1349-54.
-
(2008)
Diabetes
, vol.57
, Issue.5
, pp. 1349-1354
-
-
Ceriello, A.1
Esposito, K.2
Piconi, L.3
Ihnat, M.A.4
Thorpe, J.E.5
Testa, R.6
Boemi, M.7
Giugliano, D.8
-
7
-
-
70350751568
-
The assessment of glycemic variability and its impact on diabetes-related complications: An overview
-
Weber C, Schnell O. The assessment of glycemic variability and its impact on diabetes-related complications: an overview. Diabetes Technol Ther. 2009;11(10):623-33.
-
(2009)
Diabetes Technol Ther
, vol.11
, Issue.10
, pp. 623-633
-
-
Weber, C.1
Schnell, O.2
-
8
-
-
77953245215
-
Beyond hemoglobin A1c - need for additional markers of risk for diabetic microvascular complications
-
Hirsch IB, Brownlee M. Beyond hemoglobin A1c - need for additional markers of risk for diabetic microvascular complications. JAMA. 2010;303(22):2291-2.
-
(2010)
JAMA
, vol.303
, Issue.22
, pp. 2291-2292
-
-
Hirsch, I.B.1
Brownlee, M.2
-
9
-
-
0032775825
-
Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: The Hoorn Study
-
De Vegt F, Dekker JM, Ruhé HG, Stehouwer CD, Nijpels G, Bouter LM, Heine RJ. Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study. Diabetologia. 1999;42(8):926-31.
-
(1999)
Diabetologia
, vol.42
, Issue.8
, pp. 926-931
-
-
De Vegt, F.1
Dekker, J.M.2
Ruhé, H.G.3
Stehouwer, C.D.4
Nijpels, G.5
Bouter, L.M.6
Heine, R.J.7
-
10
-
-
0033646935
-
Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level
-
Temelkova-Kurktschiev TS, Koehler C, Henkel E, Leonhardt W, Fuecker K, Hanefeld M. Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level. Diabetes Care. 2000;23(12):1830-4.
-
(2000)
Diabetes Care
, vol.23
, Issue.12
, pp. 1830-1834
-
-
Temelkova-Kurktschiev, T.S.1
Koehler, C.2
Henkel, E.3
Leonhardt, W.4
Fuecker, K.5
Hanefeld, M.6
-
11
-
-
0042031532
-
Should postprandial glucose be measured and treated to a particular target? Yes
-
Davidson J. Should postprandial glucose be measured and treated to a particular target? Yes. Diabetes Care. 2003;26(6):1919-21.
-
(2003)
Diabetes Care
, vol.26
, Issue.6
, pp. 1919-1921
-
-
Davidson, J.1
-
12
-
-
33646338641
-
Mean blood glucose and biological variation have greater influence on HbA1c levels than glucose instability: An analysis of data from the Diabetes Control and Complications Trial
-
McCarter RJ, Hempe JM, Chalew SA. Mean blood glucose and biological variation have greater influence on HbA1c levels than glucose instability: an analysis of data from the Diabetes Control and Complications Trial. Diabetes Care. 2006;29(2):352-5.
-
(2006)
Diabetes Care
, vol.29
, Issue.2
, pp. 352-355
-
-
McCarter, R.J.1
Hempe, J.M.2
Chalew, S.A.3
-
13
-
-
33746460818
-
The effect of glucose variability on the risk of microvascular complications in type 1 diabetes
-
Kilpatrick ES, Rigby AS, Atkin SL. The effect of glucose variability on the risk of microvascular complications in type 1 diabetes. Diabetes Care. 2006;29(7):1486-90.
-
(2006)
Diabetes Care
, vol.29
, Issue.7
, pp. 1486-1490
-
-
Kilpatrick, E.S.1
Rigby, A.S.2
Atkin, S.L.3
-
14
-
-
70349653641
-
Effect of glucose variability on the long-term risk of microvascular complications in type 1 diabetes
-
Kilpatrick ES, Rigby AS, Atkin SL. Effect of glucose variability on the long-term risk of microvascular complications in type 1 diabetes. Diabetes Care. 2009;32(10):1901-3.
-
(2009)
Diabetes Care
, vol.32
, Issue.10
, pp. 1901-1903
-
-
Kilpatrick, E.S.1
Rigby, A.S.2
Atkin, S.L.3
-
15
-
-
33746441604
-
Glucose variability and complications
-
Bolli GB. Glucose variability and complications. Diabetes Care. 2006;29(7):1707-9.
-
(2006)
Diabetes Care
, vol.29
, Issue.7
, pp. 1707-1709
-
-
Bolli, G.B.1
-
16
-
-
64749114318
-
Effects of prandial versus fasting glycemia on cardiovascular outcomes in type 2 diabetes: The HEART2D trial
-
Raz I, Wilson PW, Strojek K, Kowalska I, Bozikov V, Gitt AK, Jermendy G, Campaigne BN, Kerr L, Milicevic Z, Jacober SJ. Effects of prandial versus fasting glycemia on cardiovascular outcomes in type 2 diabetes: the HEART2D trial. Diabetes Care. 2009;32(3):381-6.
-
(2009)
Diabetes Care
, vol.32
, Issue.3
, pp. 381-386
-
-
Raz, I.1
Wilson, P.W.2
Strojek, K.3
Kowalska, I.4
Bozikov, V.5
Gitt, A.K.6
Jermendy, G.7
Campaigne, B.N.8
Kerr, L.9
Milicevic, Z.10
Jacober, S.J.11
-
17
-
-
0042166232
-
Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: Variations with increasing levels of HbA(1c)
-
Monnier L, Lapinski H, Colette C. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c). Diabetes Care. 2003;26(3):881-5.
-
(2003)
Diabetes Care
, vol.26
, Issue.3
, pp. 881-885
-
-
Monnier, L.1
Lapinski, H.2
Colette, C.3
-
18
-
-
77954830051
-
Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes
-
STAR 3 Study Group
-
Bergenstal RM, Tamborlane WV, Ahmann A, Buse JB, Dailey G, Davis SN, Joyce C, Peoples T, Perkins BA, Welsh JB, Willi SM, Wood MA; STAR 3 Study Group. Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med. 2010;363(4):311-20.
-
(2010)
N Engl J Med
, vol.363
, Issue.4
, pp. 311-320
-
-
Bergenstal, R.M.1
Tamborlane, W.V.2
Ahmann, A.3
Buse, J.B.4
Dailey, G.5
Davis, S.N.6
Joyce, C.7
Peoples, T.8
Perkins, B.A.9
Welsh, J.B.10
Willi, S.M.11
Wood, M.A.12
-
19
-
-
69949146908
-
In silico preclinical trials: A proof of concept in closed-loop control of type 1 diabetes
-
Kovatchev BP, Breton M, Man CD, Cobelli C. In silico preclinical trials: A proof of concept in closed-loop control of type 1 diabetes. J Diabetes Sci Technol. 2009;3(1):44-55.
-
(2009)
J Diabetes Sci Technol
, vol.3
, Issue.1
, pp. 44-55
-
-
Kovatchev, B.P.1
Breton, M.2
Man, C.D.3
Cobelli, C.4
-
20
-
-
84857823308
-
Closed-loop insulin delivery: We're "virtually" there
-
Tamborlane WV. Closed-loop insulin delivery: we're "virtually" there. Diabetes Technol Ther. 2012;14(3):203-4.
-
(2012)
Diabetes Technol Ther
, vol.14
, Issue.3
, pp. 203-204
-
-
Tamborlane, W.V.1
-
21
-
-
77952987107
-
A bihormonal closed-loop artificial pancreas for type 1 diabetes
-
El-Khatib FH, Russell SJ, Nathan DM, Sutherlin RG, Damiano ER. A bihormonal closed-loop artificial pancreas for type 1 diabetes. Sci Transl Med. 2010;2(27):27ra27.
-
(2010)
Sci Transl Med
, vol.2
, Issue.27
-
-
El-Khatib, F.H.1
Russell, S.J.2
Nathan, D.M.3
Sutherlin, R.G.4
Damiano, E.R.5
-
22
-
-
84865117076
-
Insulin fibrillation and protein design: Topological resistance of single-chain analogs to thermal degradation with application to a pump reservoir
-
Phillips NB, Whittaker J, Ismail-Beigi F, Weiss MA. Insulin fibrillation and protein design: Topological resistance of single-chain analogs to thermal degradation with application to a pump reservoir. J Diabetes Sci Technol. 2012;6(2):277-88.
-
(2012)
J Diabetes Sci Technol
, vol.6
, Issue.2
, pp. 277-288
-
-
Phillips, N.B.1
Whittaker, J.2
Ismail-Beigi, F.3
Weiss, M.A.4
-
23
-
-
49249136821
-
A novel insulin formulation with a more rapid onset of action
-
Steiner S, Hompesch M, Pohl R, Simms P, Flacke F, Mohr T, Pfützner A, Heinemann L. A novel insulin formulation with a more rapid onset of action. Diabetologia. 2008;51(9):1602-6
-
(2008)
Diabetologia
, vol.51
, Issue.9
, pp. 1602-1606
-
-
Steiner, S.1
Hompesch, M.2
Pohl, R.3
Simms, P.4
Flacke, F.5
Mohr, T.6
Pfützner, A.7
Heinemann, L.8
-
24
-
-
77956134435
-
Intra-individual variability of the metabolic effect of a novel rapid-acting insulin (VIAject) in comparison to regular human insulin
-
Hompesch M, McManus L, Pohl R, Simms P, Pfützner A, Bülow E, Flacke F, Heinemann L, Steiner SS. Intra-individual variability of the metabolic effect of a novel rapid-acting insulin (VIAject) in comparison to regular human insulin. J Diabetes Sci Technol. 2008;2(4):568-71.
-
(2008)
J Diabetes Sci Technol
, vol.2
, Issue.4
, pp. 568-571
-
-
Hompesch, M.1
McManus, L.2
Pohl, R.3
Simms, P.4
Pfützner, A.5
Bülow, E.6
Flacke, F.7
Heinemann, L.8
Steiner, S.S.9
-
25
-
-
84857032198
-
U-100, pH-Neutral formulation of VIAject(®): Faster onset of action than insulin lispro in patients with type 1 diabetes
-
Heinemann L, Nosek L, Flacke F, Albus K, Krasner A, Pichotta P, Heise T, Steiner S. U-100, pH-Neutral formulation of VIAject(®): faster onset of action than insulin lispro in patients with type 1 diabetes. Diabetes Obes Metab. 2012;14(3):222-7.
-
(2012)
Diabetes Obes Metab
, vol.14
, Issue.3
, pp. 222-227
-
-
Heinemann, L.1
Nosek, L.2
Flacke, F.3
Albus, K.4
Krasner, A.5
Pichotta, P.6
Heise, T.7
Steiner, S.8
-
26
-
-
67649849974
-
Accelerated pharmacokinetics and glucodynamics of prandial insulins injected with recombinant human hyaluronidase
-
Vaughn DE, Yocum RC, Muchmore DB, Sugarman BJ, Vick AM, Bilinsky IP, Frost GI. Accelerated pharmacokinetics and glucodynamics of prandial insulins injected with recombinant human hyaluronidase. Diabetes Technol Ther. 2009;11(6):345-52.
-
(2009)
Diabetes Technol Ther
, vol.11
, Issue.6
, pp. 345-352
-
-
Vaughn, D.E.1
Yocum, R.C.2
Muchmore, D.B.3
Sugarman, B.J.4
Vick, A.M.5
Bilinsky, I.P.6
Frost, G.I.7
-
27
-
-
80053426508
-
Reduction in intrasubject variability in the pharmacokinetic response to insulin after subcutaneous co-administration with recombinant human hyaluronidase in healthy volunteers
-
Morrow L, Muchmore DB, Ludington EA, Vaughn DE, Hompesch M. Reduction in intrasubject variability in the pharmacokinetic response to insulin after subcutaneous co-administration with recombinant human hyaluronidase in healthy volunteers. Diabetes Technol Ther. 2011;13(10):1039-45.
-
(2011)
Diabetes Technol Ther
, vol.13
, Issue.10
, pp. 1039-1045
-
-
Morrow, L.1
Muchmore, D.B.2
Ludington, E.A.3
Vaughn, D.E.4
Hompesch, M.5
-
28
-
-
79956073035
-
Accelerated insulin pharmacokinetics and improved postprandial glycemic control in patients with type 1 diabetes after coadministration of prandial insulins with hyaluronidase
-
Hompesch M, Muchmore DB, Morrow L, Vaughn DE. Accelerated insulin pharmacokinetics and improved postprandial glycemic control in patients with type 1 diabetes after coadministration of prandial insulins with hyaluronidase. Diabetes Care. 2011;34(3):666-8.
-
(2011)
Diabetes Care
, vol.34
, Issue.3
, pp. 666-668
-
-
Hompesch, M.1
Muchmore, D.B.2
Morrow, L.3
Vaughn, D.E.4
-
29
-
-
84857833056
-
Improved postprandial glycemic control in patients with type 2 diabetes from subcutaneous injection of insulin lispro with hyaluronidase
-
Hompesch M, Muchmore DB, Morrow L, Ludington E, Vaughn DE. Improved postprandial glycemic control in patients with type 2 diabetes from subcutaneous injection of insulin lispro with hyaluronidase. Diabetes Technol Ther. 2012;14(3):218-24.
-
(2012)
Diabetes Technol Ther
, vol.14
, Issue.3
, pp. 218-224
-
-
Hompesch, M.1
Muchmore, D.B.2
Morrow, L.3
Ludington, E.4
Vaughn, D.E.5
-
30
-
-
84855831064
-
Use of recombinant human hyaluronidase to accelerate rapid insulin analogue absorption: Experience with subcutaneous injection and continuous infusion
-
Vaughn DE, Muchmore DB. Use of recombinant human hyaluronidase to accelerate rapid insulin analogue absorption: Experience with subcutaneous injection and continuous infusion. Endocr Pract. 2011;17(6):914-21.
-
(2011)
Endocr Pract
, vol.17
, Issue.6
, pp. 914-921
-
-
Vaughn, D.E.1
Muchmore, D.B.2
-
31
-
-
66949118931
-
Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion
-
Raz I, Weiss R, Yegorchikov Y, Bitton G, Nagar R, Pesach B. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion. Clin Ther. 2009;31(5):980-7.
-
(2009)
Clin Ther
, vol.31
, Issue.5
, pp. 980-987
-
-
Raz, I.1
Weiss, R.2
Yegorchikov, Y.3
Bitton, G.4
Nagar, R.5
Pesach, B.6
-
32
-
-
84856019647
-
Improved pharmacokinetic and pharmacodynamic profile of rapid-acting insulin using needle-free jet injection technology
-
Engwerda EE, Abbink EJ, Tack CJ, de Galan BE. Improved pharmacokinetic and pharmacodynamic profile of rapid-acting insulin using needle-free jet injection technology. Diabetes Care. 2011;34(8):1804-8.
-
(2011)
Diabetes Care
, vol.34
, Issue.8
, pp. 1804-1808
-
-
Engwerda, E.E.1
Abbink, E.J.2
Tack, C.J.3
De Galan, B.E.4
-
33
-
-
70449469675
-
Pharmacokinetics and linear exposure of AFRESA compared with the subcutaneous injection of regular human insulin
-
Rave K, Potocka E, Heinemann L, Heise T, Boss AH, Marino M, Costello D, Chen R. Pharmacokinetics and linear exposure of AFRESA compared with the subcutaneous injection of regular human insulin. Diabetes Obes Metab. 2009;11(7):715-20.
-
(2009)
Diabetes Obes Metab
, vol.11
, Issue.7
, pp. 715-720
-
-
Rave, K.1
Potocka, E.2
Heinemann, L.3
Heise, T.4
Boss, A.H.5
Marino, M.6
Costello, D.7
Chen, R.8
-
35
-
-
34548412091
-
Coverage of postprandial blood glucose excursions with inhaled Technosphere insulin in comparison to subcutaneously injected regular human insulin in subjects with type 2 diabetes
-
Rave K, Heise T, Pfützner A, Boss AH. Coverage of postprandial blood glucose excursions with inhaled Technosphere insulin in comparison to subcutaneously injected regular human insulin in subjects with type 2 diabetes. Diabetes Care. 2007;30(9):2307-8.
-
(2007)
Diabetes Care
, vol.30
, Issue.9
, pp. 2307-2308
-
-
Rave, K.1
Heise, T.2
Pfützner, A.3
Boss, A.H.4
-
36
-
-
77953839066
-
Prandial inhaled insulin plus basal insulin glargine versus twice daily biaspart insulin for type 2 diabetes: A multicentre randomised trial
-
Rosenstock J, Lorber DL, Gnudi L, Howard CP, Bilheimer DW, Chang PC, Petrucci RE, Boss AH, Richardson PC. Prandial inhaled insulin plus basal insulin glargine versus twice daily biaspart insulin for type 2 diabetes: a multicentre randomised trial. Lancet. 2010;375(9733):2244-53.
-
(2010)
Lancet
, vol.375
, Issue.9733
, pp. 2244-2253
-
-
Rosenstock, J.1
Lorber, D.L.2
Gnudi, L.3
Howard, C.P.4
Bilheimer, D.W.5
Chang, P.C.6
Petrucci, R.E.7
Boss, A.H.8
Richardson, P.C.9
-
37
-
-
78349238232
-
Comparison pharmacokinetics of two concentrations (0.7% and 1.0%) of Nasulin, an ultra-rapid-acting intranasal insulin formulation
-
Stote R, Marbury T, Shi L, Miller M, Strange P. Comparison pharmacokinetics of two concentrations (0.7% and 1.0%) of Nasulin, an ultra-rapid-acting intranasal insulin formulation. J Diabetes Sci Technol. 2010;4(3):603-9.
-
(2010)
J Diabetes Sci Technol
, vol.4
, Issue.3
, pp. 603-609
-
-
Stote, R.1
Marbury, T.2
Shi, L.3
Miller, M.4
Strange, P.5
-
38
-
-
79958015348
-
Enhanced absorption of Nasulin™, an ultrarapid-acting intranasal insulin formulation, using single nostril administration in normal subjects
-
Stote R, Miller M, Marbury T, Shi L, Strange P. Enhanced absorption of Nasulin™, an ultrarapid-acting intranasal insulin formulation, using single nostril administration in normal subjects. J Diabetes Sci Technol. 2011;5(1):113-9.
-
(2011)
J Diabetes Sci Technol
, vol.5
, Issue.1
, pp. 113-119
-
-
Stote, R.1
Miller, M.2
Marbury, T.3
Shi, L.4
Strange, P.5
-
39
-
-
79953230138
-
Rapid pharmacokinetics of intradermal insulin administered using microneedles in type 1 diabetes subjects
-
Gupta J, Felner EI, Prausnitz MR. Rapid pharmacokinetics of intradermal insulin administered using microneedles in type 1 diabetes subjects. Diabetes Technol Ther. 2011;13(4):451-6.
-
(2011)
Diabetes Technol Ther
, vol.13
, Issue.4
, pp. 451-456
-
-
Gupta, J.1
Felner, E.I.2
Prausnitz, M.R.3
-
40
-
-
78651255167
-
Microneedle-based intradermal delivery enables rapid lymphatic uptake and distribution of protein drugs
-
Harvey AJ, Kaestner SA, Sutter DE, Harvey NG, Mikszta JA, Pettis RJ. Microneedle-based intradermal delivery enables rapid lymphatic uptake and distribution of protein drugs. Pharm Res. 2011;28(1):107-16.
-
(2011)
Pharm Res
, vol.28
, Issue.1
, pp. 107-116
-
-
Harvey, A.J.1
Kaestner, S.A.2
Sutter, D.E.3
Harvey, N.G.4
Mikszta, J.A.5
Pettis, R.J.6
-
41
-
-
79953171920
-
Intradermal microneedle delivery of insulin lispro achieves faster insulin absorption and insulin action than subcutaneous injection
-
Pettis RJ, Ginsberg B, Hirsch L, Sutter D, Keith S, McVey E, Harvey NG, Hompesch M, Nosek L, Kapitza C, Heinemann L. Intradermal microneedle delivery of insulin lispro achieves faster insulin absorption and insulin action than subcutaneous injection. Diabetes Technol Ther. 2011;13(4):435-42.
-
(2011)
Diabetes Technol Ther
, vol.13
, Issue.4
, pp. 435-442
-
-
Pettis, R.J.1
Ginsberg, B.2
Hirsch, L.3
Sutter, D.4
Keith, S.5
McVey, E.6
Harvey, N.G.7
Hompesch, M.8
Nosek, L.9
Kapitza, C.10
Heinemann, L.11
-
42
-
-
79953230138
-
Rapid pharmacokinetics of intradermal insulin administered using microneedles in type 1 diabetes subjects
-
Gupta J, Felner EI, Prausnitz MR. Rapid pharmacokinetics of intradermal insulin administered using microneedles in type 1 diabetes subjects. Diabetes Technol Ther. 2011;13(4):451-6.
-
(2011)
Diabetes Technol Ther
, vol.13
, Issue.4
, pp. 451-456
-
-
Gupta, J.1
Felner, E.I.2
Prausnitz, M.R.3
-
43
-
-
78651255167
-
Microneedle-based intradermal delivery enables rapid lymphatic uptake and distribution of protein drugs
-
Harvey AJ, Kaestner SA, Sutter DE, Harvey NG, Mikszta JA, Pettis RJ. Microneedle-based intradermal delivery enables rapid lymphatic uptake and distribution of protein drugs. Pharm Res. 2011;28(1):107-16.
-
(2011)
Pharm Res
, vol.28
, Issue.1
, pp. 107-116
-
-
Harvey, A.J.1
Kaestner, S.A.2
Sutter, D.E.3
Harvey, N.G.4
Mikszta, J.A.5
Pettis, R.J.6
-
44
-
-
79953171920
-
Intradermal microneedle delivery of insulin lispro achieves faster insulin absorption and insulin action than subcutaneous injection
-
Pettis RJ, Ginsberg B, Hirsch L, Sutter D, Keith S, McVey E, Harvey NG, Hompesch M, Nosek L, Kapitza C, Heinemann L. Intradermal microneedle delivery of insulin lispro achieves faster insulin absorption and insulin action than subcutaneous injection. Diabetes Technol Ther. 2011;13(4):435-42.
-
(2011)
Diabetes Technol Ther
, vol.13
, Issue.4
, pp. 435-442
-
-
Pettis, R.J.1
Ginsberg, B.2
Hirsch, L.3
Sutter, D.4
Keith, S.5
McVey, E.6
Harvey, N.G.7
Hompesch, M.8
Nosek, L.9
Kapitza, C.10
Heinemann, L.11
-
45
-
-
79953209743
-
Microneedle-based intradermal versus subcutaneous administration of regular human insulin or insulin lispro: Pharmacokinetics and postprandial glycemic excursions in patients with type 1 diabetes
-
Pettis RJ, Hirsch L, Kapitza C, Nosek L, Hövelmann U, Kurth HJ, Sutter DE, Harvey NG, Heinemann L. Microneedle-based intradermal versus subcutaneous administration of regular human insulin or insulin lispro: Pharmacokinetics and postprandial glycemic excursions in patients with type 1 diabetes. Diabetes Technol Ther. 2011;13(4):443-50.
-
(2011)
Diabetes Technol Ther
, vol.13
, Issue.4
, pp. 443-450
-
-
Pettis, R.J.1
Hirsch, L.2
Kapitza, C.3
Nosek, L.4
Hövelmann, U.5
Kurth, H.J.6
Sutter, D.E.7
Harvey, N.G.8
Heinemann, L.9
-
46
-
-
78651255167
-
Microneedle-based intradermal delivery enables rapid lymphatic uptake and distribution of protein drugs
-
Harvey AJ, Kaestner SA, Sutter DE, Harvey NG, Mikszta JA, Pettis RJ. Microneedle-based intradermal delivery enables rapid lymphatic uptake and distribution of protein drugs. Pharm Res. 2011;28(1):107-16.
-
(2011)
Pharm Res
, vol.28
, Issue.1
, pp. 107-116
-
-
Harvey, A.J.1
Kaestner, S.A.2
Sutter, D.E.3
Harvey, N.G.4
Mikszta, J.A.5
Pettis, R.J.6
-
47
-
-
34447528871
-
Quantitative imaging of lymph function
-
Sharma R, Wang W, Rasmussen JC, Joshi A, Houston JP, Adams KE, Cameron A, Ke S, Kwon S, Mawad ME, Sevick-Muraca EM. Quantitative imaging of lymph function. Am J Physiol Heart Circ Physiol. 2007;292(6):H3109-18.
-
(2007)
Am J Physiol Heart Circ Physiol
, vol.292
, Issue.6
-
-
Sharma, R.1
Wang, W.2
Rasmussen, J.C.3
Joshi, A.4
Houston, J.P.5
Adams, K.E.6
Cameron, A.7
Ke, S.8
Kwon, S.9
Mawad, M.E.10
Sevick-Muraca, E.M.11
-
48
-
-
84858135604
-
Microneedle delivery: Clinical studies and emerging medical applications
-
Pettis RJ, Harvey AJ. Microneedle delivery: clinical studies and emerging medical applications. Ther Delivery. 2012;3(3):357-71.
-
(2012)
Ther Delivery
, vol.3
, Issue.3
, pp. 357-371
-
-
Pettis, R.J.1
Harvey, A.J.2
-
49
-
-
40949113163
-
Imaging of lymph flow in breast cancer patients after microdose administration of a near-infrared fluorophore: Feasibility study
-
Sevick-Muraca EM, Sharma R, Rasmussen JC, Marshall MV, Wendt JA, Pham HQ, Bonefas E, Houston JP, Sampath L, Adams KE, Blanchard DK, Fisher RE, Chiang SB, Elledge R, Mawad ME. Imaging of lymph flow in breast cancer patients after microdose administration of a near-infrared fluorophore: feasibility study. Radiology. 2008;246(3):734-41.
-
(2008)
Radiology
, vol.246
, Issue.3
, pp. 734-741
-
-
Sevick-Muraca, E.M.1
Sharma, R.2
Rasmussen, J.C.3
Marshall, M.V.4
Wendt, J.A.5
Pham, H.Q.6
Bonefas, E.7
Houston, J.P.8
Sampath, L.9
Adams, K.E.10
Blanchard, D.K.11
Fisher, R.E.12
Chiang, S.B.13
Elledge, R.14
Mawad, M.E.15
-
50
-
-
79959774659
-
Postprandial hyperglycemia and glycemic variability: Should we care?
-
Standl E, Schnell O, Ceriello A. Postprandial hyperglycemia and glycemic variability: should we care? Diabetes Care. 2011;34 Suppl 2:S120-7.
-
(2011)
Diabetes Care
, vol.34
, Issue.SUPPL. 2
-
-
Standl, E.1
Schnell, O.2
Ceriello, A.3
|